The company was founded in 2009 as a spin-off of the University of Greifswald and focuses on innovative test equipment and methods to examine the release of pharmaceuticals.
The company has developed methods and products for preclinical evaluation and especially predictive pharmacopoeial dissolution testing under bio-relevant test conditions. The analytical services of the company include also further pharmacopoeial investigations of solid oral dosage forms and their mechanical stability as well as development and validation of analytical methods and procedures.
Biochemical characterisation of biomolecules are also on the market, e.g. characterization of proteins/peptides under denaturing and native conditions and determination of protein concentration.
The company looks for laboratories or industry partners dealing with enzymatic assays and kits for determination of biological markers and selected proteins from human biological materials. The partners would benefit from offered testing and evaluation under service agreement.